Paper8944332
Influence of the extraction procedure on plasminogen activator inhibitor-2 (PAI-2) and urokinase receptor (uPAR) assays in breast cancer tissues.
Bouchet-Bernet C and 5 others. Breast Cancer Res Treat, 1996. Cited by 13 papers, by iCite.
Cite this record
ConductScience Library. Influence of the extraction procedure on plasminogen activator inhibitor-2 (PAI-2) and urokinase receptor (uPAR) assays in breast cancer tissues. Papers, record 8944332. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8944332
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Influence of the extraction procedure on plasminogen activator inhibitor-2 (PAI-2) and urokinase receptor (uPAR) assays in breast cancer tissues.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Plasminogen Activator Inhibitor 2 | Major topic |
| Receptors, Cell Surface | Major topic |
| Buffers | |
| Chemistry Techniques, Analytical | |
| Enzyme-Linked Immunosorbent Assay | |
| Female | |
| Humans | |
| Octoxynol | |
| Receptors, Urokinase Plasminogen Activator | |
| Time Factors |
Source PubMed
References16
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1648443 | Role of the urokinase receptor in facilitating extracellular matrix invasion by cultured colon cancer. | Cancer Res | 1991 | https://conductscience.org/library/papers/1648443 | PubMed |
| 2 | 1796300 | Clinical relevance of the urokinase-type and tissue-type plasminogen activators and of their type 1 inhibitor in breast cancer. | Semin Thromb Hemost | 1991 | https://conductscience.org/library/papers/1796300 | PubMed |
| 3 | 7882345 | Plasminogen activator inhibitor-2: prognostic relevance in 1012 patients with primary breast cancer. | Cancer Res | 1995 | https://conductscience.org/library/papers/7882345 | PubMed |
| 4 | 3134120 | Urokinase-plasminogen activator, a marker for aggressive breast carcinomas. Preliminary report. | Cancer | 1988 | https://conductscience.org/library/papers/3134120 | PubMed |
| 5 | 1850957 | Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas. | Am J Pathol | 1991 | https://conductscience.org/library/papers/1850957 | PubMed |
| 6 | 8297742 | Prognostic value of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in breast carcinomas. | Br J Cancer | 1994 | https://conductscience.org/library/papers/8297742 | PubMed |
| 7 | 3245570 | Investigation of the bicinchoninic acid protein assay: identification of the groups responsible for color formation. | Anal Biochem | 1988 | https://conductscience.org/library/papers/3245570 | PubMed |
| 8 | 8040677 | Plasminogen activator inhibitor-1 and prognosis in primary breast cancer. | J Clin Oncol | 1994 | https://conductscience.org/library/papers/8040677 | PubMed |
| 9 | 8313371 | The urokinase receptor is expressed in invasive breast cancer but not in normal breast tissue. | Cancer Res | 1994 | https://conductscience.org/library/papers/8313371 | PubMed |
| 10 | 8611670 | Comparative study of four extraction procedures for urokinase type plasminogen activator and plasminogen activator inhibitor-1 in breast cancer tissues. | Eur J Clin Chem Clin Biochem | 1995 | https://conductscience.org/library/papers/8611670 | PubMed |
| 11 | 1640487 | Multiparametric prognostic evaluation of biological factors in primary breast cancer. | J Natl Cancer Inst | 1992 | https://conductscience.org/library/papers/1640487 | PubMed |
| 12 | 7749147 | Urokinase receptor in breast cancer tissue extracts. Enzyme-linked immunosorbent assay with a combination of mono- and polyclonal antibodies. | Breast Cancer Res Treat | 1995 | https://conductscience.org/library/papers/7749147 | PubMed |
| 13 | 1735602 | Plasminogen activator system in human breast cancer. | Int J Cancer | 1992 | https://conductscience.org/library/papers/1735602 | PubMed |
| 14 | 7768629 | Urokinase plasminogen activator and urokinase plasminogen activator receptor in breast cancer. | Int J Cancer | 1995 | https://conductscience.org/library/papers/7768629 | PubMed |
| 15 | 8435475 | Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancer. | Breast Cancer Res Treat | 1993 | https://conductscience.org/library/papers/8435475 | PubMed |
| 16 | 8388317 | High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis. | Cancer Res | 1993 | https://conductscience.org/library/papers/8388317 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 34917087 | CD38 Defines a Subset of B Cells in Rainbow Trout Kidney With High IgM Secreting Capacities. | Front Immunol | 2021 | https://conductscience.org/library/papers/34917087 | PubMed |
| 25519168 | Prognostic impact of urokinase-type plasminogen activator system components in clear cell renal cell carcinoma patients without distant metastasis. | BMC Cancer | 2014 | https://conductscience.org/library/papers/25519168 | PubMed |
| 9652768 | Prognostic value of urokinase plasminogen activator in primary breast carcinoma: comparison of two immunoassay methods. | Br J Cancer | 1998 | https://conductscience.org/library/papers/9652768 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| PLAU | 5328 | PubTator's text mining | https://conductscience.org/library/genes/5328 | NCBI Gene |
| PLAUR | 5329 | PubTator's text mining | https://conductscience.org/library/genes/5329 | NCBI Gene |
| SERPINB2 | 5055 | PubTator's text mining | https://conductscience.org/library/genes/5055 | NCBI Gene |
| SERPINE1 | 5054 | PubTator's text mining | https://conductscience.org/library/genes/5054 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8944332
GET https://conductscience.org/api/papers/v1/8944332/authors